Table 4.

A comparison of improvements in Walking Impairment Questionnaire score in patients with peripheral arterial disease between TJ-7 in our research and cilostazol in Regensteiner’s report¹⁹⁾

Score	Baseline	Follow-up	Absolute change
Pain
Placebo	38 ± 25	47 ± 27	9 ± 28
Cilostazol	41 ± 24	55 ± 27	15 ± 28
TJ-7	28.6 ± 27.5	75.0 ± 21.9	46.4 ± 32.3
Distance
Placebo	29 ± 26	35 ± 29	6 ± 25
Cilostazol	32 ± 27	43 ± 32	11 ± 27
TJ-7	37.3 ± 34.2	68.6 ± 40.8	31.3 ± 30.4
Speed
Placebo	37 ± 27	40 ± 27	3 ± 26
Cilostazol	39 ± 28	47 ± 30	8 ± 26
TJ-7	30.5 ± 21.7	56.0 ± 40.1	25.5 ± 26.7
Climbing
Placebo	47 ± 33	49 ± 33	2 ± 30
Cilostazol	49 ± 33	55 ± 35	6 ± 28
TJ-7	57.5 ± 34.2	72.5 ± 36.0	15.0 ± 28.2

Values are expressed as the mean ± standard deviation. TJ-7: Tsumura Hachimi-jio-gan extract granules for medical use